Pikkelysömör: vizsgálatok itt: Kína
49 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
- Where
- Beijing, Chengde, Hangzhou, Jinan, Shijiazhuang, Shiyan, Taiyuan, Wenzhou, Xi'an, Yiwu
- Életkor
- 18 év to 70 év
- People
- 220
- Run by
- Chipscreen Biosciences, Ltd.
See details and how to joinNCT07129382 - 3. fázisTaking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Beijing, Changzhou, Hangzhou, Shanghai, Shenyang
- Életkor
- 3 év to 64 év
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - 3. fázisTaking peopleLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Where
- Beijing, Bengbu, Changchun, Changsha Shi, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Jiaxing, Jinan, Nanjing, Ningbo, Shenyang, Shenzhen, Shijiazhuang, Taiyuan, Wenzhou, Wuhan, Xi'an, Zhengzhou, Zhenjiang
- Életkor
- 40 év and over
- People
- 3040 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Beijing, Changsha, Chengdu, Guangzhou, Handan, Hangzhou, Jinan, Shanghai, Shenzhen, Zhengzhou
- Életkor
- 12 év to 17 év
- People
- 366 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00 - 2. fázisTaking peopleAn Open-label Study of HS-20137 in Participants With Moderate-to-Severe Plaque Psoriasis
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 390
- Run by
- Hansoh BioMedical R&D Company
See details and how to joinNCT07879885 - No phaseTaking peopleA Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis
- Where
- Xi'an
- Életkor
- 18 év to 65 év
- People
- 3
- Run by
- Xijing Hospital
See details and how to joinNCT07780929 - 3. fázisTaking peopleA Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
- Where
- Beijing, Changsha, Guangzhou, Hangzhou, Shanghai
- Életkor
- 4 év to 17 év
- People
- 110 worldwide
- Run by
- Takeda
See details and how to joinNCT07250802 · EU 2025-522567-15-00 - 3. fázisTaking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Baotou Shi, Beijing, Bengbu, Chengdu, Guangzhou, Linyi Shi, Pingxiang, Taiyuan, Wuhan, Zhuzhou
- Életkor
- 18 év and over
- People
- 1182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - 3. fázisTaking peopleA Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis
- Where
- Beijing, Changchun, Changsha, Changzhi, Chengde, Chongqing, Dezhou, Guangzhou, Guiyang, Haikou, Harbin, Hohhot, Jiaxing, Jingzhou, Jinhua, Jining, Kunming, Lianyungang, Luoyang, Nanjing, Nanning, Nantong, Ningbo, Puyang, Qingdao, Shanghai, Shengyang, Shenyang, Shenzhen, Shijiazhuang, Suining, Suzhou, Tianjin, Xi'an, Xining, Yinchuan, Zhengzhou, Zhenjiang
- Életkor
- 18 év to 75 év
- People
- 400
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07724366 - 2. fázisTaking peopleA Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
- Where
- Baoding, Beijing, Bozhou, Cangzhou, Changchun, Changsha, Chongqing, Dalian, Deyang, Dongguan, Guangzhou, Guiyang, Hangzhou, Jiangmen, Jinan, Kaifeng, Linfen, Luoyang, Luzhou, Nanchang, Nanchong, Nanjing, Nanning, Ningbo, Pingxiang, Puyang, Shanghai, Shaoyang, Shenyang, Shenzhen, Suzhou, Tianjin, Ürümqi, Weifang, Yancheng, Zhengzhou, Zhuzhou
- Életkor
- 18 év to 70 év
- People
- 156
- Run by
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
See details and how to joinNCT07406035 - No phaseCsak meghívásosMass Spectrometry-based Immune Profiling in Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 500
- Run by
- Peking University People's Hospital
See details and how to joinNCT07188285 - 2. fázisTaking peoplePhase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 60
- Run by
- Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07719530 - 2. fázisNot yet taking people in KínaA Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque Psoriasis
- Where
- Changsha
- Életkor
- 18 év and over
- People
- 50
- Run by
- Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07758075 - 4. fázisTaking peopleA Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 30
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07663331 - 3. fázisTaking peopleA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 375
- Run by
- Zhejiang Wenda Pharma Technology LTD.
See details and how to joinNCT07672561 - No phaseNot yet taking people in KínaEffects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 120
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07642544 - No phaseCsak meghívásosA Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque Psoriasis With Eczematous Features
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 50
- Run by
- Xi Tan
See details and how to joinNCT06999941 - 3. fázisTaking peopleA Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 477
- Run by
- InventisBio Co., Ltd
See details and how to joinNCT07326813 - 2. fázisTaking peopleA Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis
- Where
- Chengdu
- Életkor
- 18 év to 70 év
- People
- 222
- Run by
- InventisBio Co., Ltd
See details and how to joinNCT07315061 - 3. fázisNot yet taking people in KínaA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 600
- Run by
- Reistone Biopharma Company Limited
See details and how to joinNCT07543224 - No phaseTaking peopleA Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 400
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07532486 - 4. fázisNot yet taking people in KínaMetformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 186
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07485764 - 2/3. fázisTaking peopleA Study of Picankibart in Patients With Active Psoriatic Arthritis
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 222
- Run by
- Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07295509 - 2/3. fázisNot yet taking people in KínaA Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment of Adult Patients With Moderate to Severe Plaque-type Psoriasis
- Where
- Beijing, Bengbu, Changchun, Chengde, Guangzhou, Handan, Hangzhou, Harbin, Jinan, Jining, Nanyang, Sanmenxia, Shanghai, Shijiazhuang, Wuhu, Wuxi, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 540
- Run by
- Dermavon Holdings Limited
See details and how to joinNCT07432854 - 3. fázisTaking peopleEfficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
- Where
- Beijing, Changchun, Changsha, Changzhou, Chengde, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Guiyang, Hangzhou, Harbin, Hefei, Jinan, Jingzhou, Jinhua, Kunming, Lianyungang, Liuzhou, Luoyang, Nanchang, Nanjing, Nanyang, Ningbo, Sanmenxia, Shanghai, Shenyang, Shijiazhuang, Taiyuan, Tianjin, Wenzhou, Wuhan, Wuhu, Xi'an, Xi’an, Zhengzhou
- Életkor
- 18 év to 75 év
- People
- 383
- Run by
- Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06842199